Two's Company, Three’s a Crowd: The pre-eminence of genetic identity in the proposed regulation of mitochondrial replacement therapy

Activity: Academic talk or presentation typesOral presentation

Period2016
Event titleFAB
Event typeConference
LocationUnited KingdomShow on map